Nanjing Vishee Medical Technology Co., Ltd (688580.SS)
CNY 31.76
(-4.31%)
CNY 31.76
(-4.31%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 462.22 Million CNY | 43.72% |
| 2022 | 321.62 Million CNY | -25.21% |
| 2021 | 430.04 Million CNY | 13.66% |
| 2020 | 378.36 Million CNY | 18.66% |
| 2019 | 318.87 Million CNY | 53.47% |
| 2018 | 207.78 Million CNY | 43.8% |
| 2017 | 144.49 Million CNY | 50.67% |
| 2016 | 95.9 Million CNY | 19.13% |
| 2015 | 80.5 Million CNY | 38.42% |
| 2014 | 58.16 Million CNY | 19.05% |
| 2013 | 48.85 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 100.17 Million CNY | -2.31% |
| 2024 Q1 | 87.67 Million CNY | -32.79% |
| 2024 Q2 | 102.55 Million CNY | 16.97% |
| 2023 Q3 | 111.97 Million CNY | -9.88% |
| 2023 FY | 462.22 Million CNY | 43.72% |
| 2023 Q4 | 130.44 Million CNY | 16.5% |
| 2023 Q2 | 124.25 Million CNY | 30.06% |
| 2023 Q1 | 95.53 Million CNY | -9.05% |
| 2022 Q2 | 80.01 Million CNY | 47.89% |
| 2022 Q1 | 54.1 Million CNY | -57.31% |
| 2022 Q4 | 105.04 Million CNY | 27.39% |
| 2022 FY | 321.62 Million CNY | -25.21% |
| 2022 Q3 | 82.45 Million CNY | 3.04% |
| 2021 FY | 430.04 Million CNY | 13.66% |
| 2021 Q1 | 80.19 Million CNY | -34.95% |
| 2021 Q2 | 111.23 Million CNY | 38.69% |
| 2021 Q3 | 111.88 Million CNY | 0.59% |
| 2021 Q4 | 126.73 Million CNY | 13.27% |
| 2020 Q3 | 98.05 Million CNY | -1.96% |
| 2020 Q1 | 57.01 Million CNY | -39.01% |
| 2020 Q4 | 123.28 Million CNY | 25.74% |
| 2020 Q2 | 100 Million CNY | 75.4% |
| 2020 FY | 378.36 Million CNY | 18.66% |
| 2019 Q3 | 85.27 Million CNY | 5.28% |
| 2019 Q4 | 93.48 Million CNY | 9.63% |
| 2019 Q2 | 80.99 Million CNY | 37.0% |
| 2019 Q1 | 59.11 Million CNY | 0.0% |
| 2019 FY | 318.87 Million CNY | 53.47% |
| 2018 FY | 207.78 Million CNY | 43.8% |
| 2017 FY | 144.49 Million CNY | 50.67% |
| 2016 Q1 | 20.05 Million CNY | 0.0% |
| 2016 FY | 95.9 Million CNY | 19.13% |
| 2016 Q2 | 20.05 Million CNY | 0.0% |
| 2015 Q1 | 16.03 Million CNY | 0.0% |
| 2015 FY | 80.5 Million CNY | 38.42% |
| 2015 Q2 | 16.03 Million CNY | -0.0% |
| 2014 FY | 58.16 Million CNY | 19.05% |
| 2013 FY | 48.85 Million CNY | 0.0% |